On May 23, the U.S. District Court for the District of Columbia issued a decision striking down the 340B orphan drug rule that was finalized by the Health Services and Resources Administration (HRSA) in July 2013 and took effect Oct. 1, 2013.
In this month's edition of McKnight's Long Term Care News & Assisted Living, Avalere's Sally Rodriguez wrote a guest blog discussing value-based payment strategies for post-acute care (PAC) providers, given the Affordable Care Act's (ACA) current focus on value over volume.
On May 19, CMS released the Final Rule on policy changes to the Medicare Advantage (MA) and Medicare Part D programs for Contract Year (CY) 2015.
A new analysis from Avalere Health finds that individuals choosing an exchange plan based on premiums are most likely to consider plans from Coventry (acquired by Aetna in 2013), Humana, and WellPoint in regions where they participate.
On May 16, HHS released the final Exchange and Insurance Market Standards for 2015 and Beyond rule.
More and more, pharmacists are forging expanded roles in healthcare delivery to ensure optimal drug therapy and improve patient outcomes.
On May 14, CMS released a proposed national coverage determination (NCD) for Transcatheter Mitral Valve Repair (TMVR), and proposed to cover TMVR under its Coverage with Evidence Development (CED) program.
On May 13, FDA released a draft guidance describing the clinical pharmacology data needed to support a demonstration of biosimilarity to a reference product.
On April 9, HHS made public CMS reimbursement data for 880,000 Medicare providers for the first time in the Agency's history; but the bigger story was the social media response that followed.
On May 14, the Health Care Cost Institute (HCCI) announced that it will work with Aetna, Humana and, UnitedHealthcare to provide consumers free access to an online tool that displays information about the price and quality of healthcare services beginning in 2015.
As of May 15, 2014, 28 states and D.C. are expanding Medicaid eligibility.
Avalere is pleased to announce a new formalized collaboration with Michael “Buz” Waitzkin.
At least four states -- Arizona, Colorado, Louisiana and Missouri -- have recently proposed bills that would allow physicians to prescribe investigational drugs, biologics or devices to eligible terminally ill patients.
2014 has accomplished a great deal in terms of patient access, with the establishment of the exchange plans and the exchange market.
Over 550K New Medicaid Enrollees Gained Coverage in Non-Expansion States in First Quarter.
On May 5, the American Society of Clinical Oncology (ASCO) released a novel methodology for physician payment for cancer care services under Medicare.
Pharmaceutical companies are facing multiple challenges in the constantly evolving healthcare landscape.
Last week, the Department of Health and Human Services (HHS) announced that 8 million people enrolled in exchanges nationwide.
Analysis assumes 85 percent of enrollees pay first month's premium.
Malnutrition is a leading cause of morbidity and mortality, especially among the elderly.
